review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0083-6729(06)74007-9 |
P698 | PubMed publication ID | 17027515 |
P2093 | author name string | Pankaj Sharma | |
S Jaharul Haque | |||
P2860 | cites work | The Janus kinases (Jaks) | Q21194856 |
Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells | Q22009002 | ||
Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors | Q22254187 | ||
Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R | Q22254431 | ||
Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain | Q24290190 | ||
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 | Q24290619 | ||
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling | Q24290848 | ||
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R | Q24297906 | ||
Identification of a nuclear Stat1 protein tyrosine phosphatase | Q24302061 | ||
Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway | Q24305237 | ||
Requirements for interleukin-4-induced gene expression and functional characterization of Stat6 | Q24308078 | ||
cDNA cloning, expression and chromosome mapping of the human STAT4 gene: both STAT4 and STAT1 genes are mapped to 2q32.2-->q32.3 | Q24309161 | ||
Inhibition of Stat1-mediated gene activation by PIAS1 | Q24310082 | ||
Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells. | Q54118063 | ||
Amino-terminal signal transducer and activator of transcription (STAT) domains regulate nuclear translocation and STAT deactivation. | Q54258378 | ||
Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. | Q55066450 | ||
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2 | Q57054898 | ||
Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro | Q57055052 | ||
A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130 | Q57272697 | ||
Structural comparisons among the short-chain helical cytokines | Q57904799 | ||
Identification of Critical Residues Required for Suppressor of Cytokine Signaling-specific Regulation of Interleukin-4 Signaling | Q58666184 | ||
Roles of Protein-tyrosine Phosphatases in Stat1 -mediated Cell Signaling | Q58666537 | ||
STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells. | Q64968569 | ||
Distribution of the mammalian Stat gene family in mouse chromosomes | Q70807902 | ||
Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway | Q71468319 | ||
Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3 | Q71542082 | ||
Defective lymphoid development in mice lacking Jak3 | Q71542089 | ||
Localization of genes for two members of the JAK family of protein tyrosine kinases to murine chromosomes 4 and 19 | Q71882789 | ||
Immune response in Stat2 knockout mice | Q73406523 | ||
The mechanism of IL-5 signal transduction | Q77217607 | ||
Granulocyte colony-stimulating factor activates a 72-kDa isoform of STAT3 in human neutrophils | Q77584426 | ||
Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes | Q77659000 | ||
Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice | Q77725481 | ||
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis | Q78836958 | ||
A peek at PIAS | Q80501651 | ||
Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains | Q24310724 | ||
Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells | Q24311526 | ||
A family of cytokine-inducible inhibitors of signalling | Q24313168 | ||
Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes | Q24313200 | ||
A new protein containing an SH2 domain that inhibits JAK kinases | Q24313242 | ||
Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase | Q24314333 | ||
Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis | Q24316448 | ||
Identification of amino acid residues critical for the Src-homology 2 domain-dependent docking of Stat2 to the interferon alpha receptor | Q24317719 | ||
The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction | Q24319109 | ||
IL-28, IL-29 and their class II cytokine receptor IL-28R | Q24323830 | ||
Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA | Q24336371 | ||
IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex | Q24336912 | ||
Principles of interleukin (IL)-6-type cytokine signalling and its regulation | Q24530173 | ||
Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3 | Q24535580 | ||
Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. | Q24537294 | ||
Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta | Q24538513 | ||
Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation | Q24538645 | ||
The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction | Q24564242 | ||
JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region | Q24612039 | ||
Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region | Q24628753 | ||
STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation | Q24644334 | ||
The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation | Q24654107 | ||
Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction | Q24654170 | ||
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality | Q24685515 | ||
Crystal structure of the tyrosine kinase domain of the human insulin receptor | Q27730800 | ||
Three-dimensional structure of the Stat3beta homodimer bound to DNA | Q27764842 | ||
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains | Q27860528 | ||
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
How cells respond to interferons | Q27861006 | ||
Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription | Q33938819 | ||
Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes | Q33941385 | ||
Serine phosphorylation of STATs | Q33941422 | ||
Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. | Q33943220 | ||
Signaling by type I and II cytokine receptors: ten years after | Q33951373 | ||
Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver | Q33967216 | ||
Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1 | Q34065588 | ||
Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha | Q34086377 | ||
Cytokine signaling in 2002: new surprises in the Jak/Stat pathway | Q34126053 | ||
The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions | Q34146819 | ||
Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions | Q34152063 | ||
The Stat family in cytokine signaling | Q34180677 | ||
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines | Q34264032 | ||
Inhibitors of cytokine signal transduction | Q34275568 | ||
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells | Q34388169 | ||
Genomic sequence, organization, and chromosomal localization of human JAK3. | Q34407583 | ||
New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway. | Q34412332 | ||
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses | Q34468309 | ||
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses | Q34468846 | ||
Cytokines and immunodeficiency diseases | Q34572193 | ||
Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling | Q34584978 | ||
JAK-STAT signaling in asthma | Q34647024 | ||
A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5 | Q34662194 | ||
Nuclear export signal located within theDNA-binding domain of the STAT1transcription factor | Q34679479 | ||
Cytokine and cytokine receptor pleiotropy and redundancy | Q34693494 | ||
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. | Q34759631 | ||
STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity | Q34762373 | ||
CD45: a critical regulator of signaling thresholds in immune cells | Q34987899 | ||
An epigenetic view of helper T cell differentiation | Q35164202 | ||
Molecular phylogeny within type I cytokines and their cognate receptors | Q35204511 | ||
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. | Q35207498 | ||
Lineage-specific negative regulation of STAT-mediated signaling by proteolytic processing | Q35209134 | ||
The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families | Q35211894 | ||
Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 | Q28637521 | ||
Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression | Q28638072 | ||
Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types | Q28638350 | ||
Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins | Q28645718 | ||
Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein | Q28646262 | ||
STATs and gene regulation | Q29547796 | ||
The STATs of cancer--new molecular targets come of age | Q29614601 | ||
Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease | Q29615967 | ||
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway | Q29615968 | ||
Active and inactive protein kinases: structural basis for regulation | Q29616320 | ||
Structural design and molecular evolution of a cytokine receptor superfamily | Q29618154 | ||
Jaks and STATs: biological implications | Q29619657 | ||
Transcriptional responses to polypeptide ligands: the JAK-STAT pathway | Q29620287 | ||
Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. | Q33183255 | ||
Negative regulation of the JAK/STAT pathway | Q33539658 | ||
Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation | Q33559005 | ||
The STAT family of proteins in cytokine signaling | Q33650629 | ||
Negative regulation of NF-kappaB signaling by PIAS1. | Q33714545 | ||
Cytokines and JAK-STAT signaling | Q33783480 | ||
Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes | Q33921809 | ||
Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function | Q33924665 | ||
A protein tyrosine kinase in the interferon alpha/beta signaling pathway | Q28116574 | ||
IL-4/IL-13 signaling beyond JAK/STAT | Q28138418 | ||
Gigantism in mice lacking suppressor of cytokine signalling-2 | Q28140549 | ||
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction | Q28140805 | ||
SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality | Q28144528 | ||
SOCS3 is essential in the regulation of fetal liver erythropoiesis | Q28144536 | ||
The IL-4 receptor: signaling mechanisms and biologic functions | Q28198739 | ||
PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4 | Q28201360 | ||
The SOCS box: a tale of destruction and degradation | Q28205975 | ||
Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction | Q28208174 | ||
SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130 | Q28211408 | ||
TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression | Q28211551 | ||
Protein phosphatase 2A (PP2A) regulates interleukin-4-mediated STAT6 signaling | Q28214491 | ||
Novel interferons | Q28218804 | ||
Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2 | Q28242524 | ||
Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells | Q28244421 | ||
Interleukin-10 and related cytokines and receptors | Q28251518 | ||
STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. | Q28253106 | ||
Specific inhibition of Stat3 signal transduction by PIAS3 | Q28255665 | ||
Cytokine signal transduction | Q28258951 | ||
Regulation of gene-activation pathways by PIAS proteins in the immune system | Q28264801 | ||
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice | Q28265772 | ||
Characterization of the signaling capacities of the novel gp130-like cytokine receptor | Q28266811 | ||
Jak2 is essential for signaling through a variety of cytokine receptors | Q28270987 | ||
Assignment of the STAT6 gene (STAT6) to human chromosome band 12q13 by in situ hybridization | Q28272253 | ||
Essential role of Stat6 in IL-4 signalling | Q28276199 | ||
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene | Q28276209 | ||
A Novel Sequence in the Coiled-coil Domain of Stat3 Essential for Its Nuclear Translocation | Q28505954 | ||
Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium | Q28513906 | ||
Structure and function of a new STAT-induced STAT inhibitor | Q28584775 | ||
Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism | Q28585612 | ||
Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction | Q28588105 | ||
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses | Q28592023 | ||
Interleukin 20: discovery, receptor identification, and role in epidermal function | Q28593930 | ||
Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. | Q40988710 | ||
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice | Q41185362 | ||
Elucidation of the basic three-dimensional structure of type I interferons and its functional and evolutionary implications. | Q41511507 | ||
Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway | Q41514580 | ||
Assignment of a novel protein tyrosine phosphatase gene (Hcph) to mouse chromosome 6. | Q41595593 | ||
Interferon-alpha activates binding of nuclear factors to a sequence element in the c-fos proto-oncogene 5'-flanking region | Q41600016 | ||
Shared architecture of hormone binding domains in type I and II interferon receptors | Q42630904 | ||
Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis | Q42679964 | ||
Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones | Q42767900 | ||
Characterization of the Stat5 protease | Q42811119 | ||
Roles of the cytoplasmic domains of the alpha and beta subunits of human granulocyte-macrophage colony-stimulating factor receptor. | Q42819905 | ||
Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity | Q43814564 | ||
Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. | Q44021327 | ||
Components of a Stat recognition code: evidence for two layers of molecular selectivity | Q44747920 | ||
Cell signaling. Stat acetylation--a key facet of cytokine signaling? | Q45226467 | ||
PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. | Q46006991 | ||
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages | Q46376203 | ||
Jak3 maps to chromosome 8. | Q46548131 | ||
PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells | Q46592704 | ||
Stat5a is mandatory for adult mammary gland development and lactogenesis. | Q48055024 | ||
Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene | Q48111435 | ||
The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. | Q51085641 | ||
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. | Q52174469 | ||
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. | Q52204302 | ||
Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. | Q52537943 | ||
Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. | Q52543788 | ||
Virtual gating and nuclear transport: the hole picture | Q35587487 | ||
Regulation of JAK-STAT signalling in the immune system | Q35605437 | ||
Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. | Q35626895 | ||
The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response | Q35698515 | ||
A new modality for immunosuppression: targeting the JAK/STAT pathway | Q35825869 | ||
Mechanisms of soluble cytokine receptor generation | Q35923165 | ||
DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1. | Q35967250 | ||
Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. | Q36076075 | ||
STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells | Q36161667 | ||
Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1 | Q36351256 | ||
The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis | Q36376720 | ||
Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production | Q36400465 | ||
Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice | Q36400723 | ||
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice | Q36497106 | ||
Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. | Q36548039 | ||
Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling | Q36638911 | ||
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression | Q36653664 | ||
Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases | Q36745947 | ||
Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. | Q36813436 | ||
Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation | Q37493064 | ||
Haemopoietic receptors and helical cytokines | Q37895794 | ||
Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor | Q38287574 | ||
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis | Q38290076 | ||
Leptin activates Stat3, Stat1 and AP-1 in mouse adipose tissue | Q38306983 | ||
How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene | Q38309989 | ||
SOCS3 regulates the plasticity of gp130 signaling | Q38354507 | ||
SOCS3 negatively regulates IL-6 signaling in vivo | Q38354512 | ||
Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells | Q38359739 | ||
STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells | Q39122429 | ||
Regulation of Stat3 nuclear export | Q39741143 | ||
Serine phosphorylation of Stat6 negatively controls its DNA-binding function | Q40369583 | ||
Cytokine receptor signalling | Q40416594 | ||
Alpha and beta interferons and their receptor and their friends and relations. | Q40467356 | ||
Dimerization of cell surface receptors in signal transduction | Q40579106 | ||
Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx. | Q40609503 | ||
Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells | Q40685493 | ||
SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei | Q40701903 | ||
IL-4 induces the proteolytic processing of mast cell STAT6. | Q40702315 | ||
Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3. | Q40764229 | ||
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. | Q40816941 | ||
The type-I interferon receptor. The long and short of it. | Q40931099 | ||
P304 | page(s) | 165-206 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Vitamins and Hormones | Q15753296 |
P1476 | title | Interleukins and STAT signaling | |
P478 | volume | 74 |
Q33651034 | A Short Receptor Downregulates JAK/STAT Signalling to Control the Drosophila Cellular Immune Response |
Q35230410 | Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251. |
Q89621140 | Galectin-9 Induced by Dietary Probiotic Mixture Regulates Immune Balance to Reduce Atopic Dermatitis Symptoms in Mice |
Q55502636 | IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumors. |
Q39679931 | Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells |
Q34276089 | JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy |
Q42589687 | Molecular mechanisms of mouse skin tumor promotion |
Q35148141 | PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model |
Q37073431 | Redox regulation of interleukin-4 signaling |
Q33656976 | Stat3 activation is required for the growth of U87 cell-derived tumours in mice |
Q37747165 | Structure and function of interleukin-22 and other members of the interleukin-10 family |
Q58776756 | Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway |
Q38922507 | Vanadium pentoxide prevents NK-92MI cell proliferation and IFNγ secretion through sustained JAK3 phosphorylation. |
Search more.